Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes
A.A.K. Abdel Razeka,
A.Y. Kandeela,
N. Solimana,
H.M. El-shenshawyb,
Y. Kamelc,
N. Nadae and
A. Deneward
a Departments of Diagnostic Radiology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
b Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt
c ENT and Head and Neck Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt
d Oncology Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt
e Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
View larger version (70K):
[in this window]
[in a new window]
|
Fig 2. Recurrent oncocytic carcinoma of the right parotid gland.
A, Axial T2WI, shown as ill defined, is seen at the site of the right parotid region after surgical resection and irradiation.
B, Axial postcontrast T1WI shows the inhomogenous pattern of enhancement. Recurrence could not be excluded.
C, ADC map shows low signal intensity at the site of the lesion with a mean ADC value of 1.07 ± 0.18 x 10–3 mm2/s. Biopsy revealed recurrent tumor.
| |
View larger version (80K):
[in this window]
[in a new window]
|
Fig 3. Recurrent squamous cell carcinoma of the nasal cavity.
A, Axial postcontrast T1-weighted MR image shows that enhancing lesion is seen in the right side of the nasal cavity. Recurrent tumor cannot be differentiated from postradiation changes.
B, ADC map shows hypointensity within the lesion with a low ADC value (1.17 ± 0.17 x 10–3 mm2/s).
| |
View larger version (75K):
[in this window]
[in a new window]
|
Fig 4. Recurrent squamous cell carcinoma of the oropharynx with metastatic cervical lymph node.
A, Axial T2WI shows an ill-defined irregular mass of inhomogeneous signal intensity involving the right side of the oropharynx. An enlarged cervical lymph node (arrow) with inhomogeneous high signal intensity is also noted at the right side of the neck.
B, ADC map shows low signal intensity of both the lesion and the lymph node with a mean ADC value of 1.20 ± 0.22 x 10–3 mm2/s and 1.05 ± 0.20 x 10–3 mm2/s, respectively, suggestive of tumor recurrence with metastatic lymph nodes. This was proved by biopsy.
| |
View larger version (59K):
[in this window]
[in a new window]
|
Fig 5. Bone marrow infiltration.
A, Axial T2-weighted MR image shows an ill-defined inhomogeneous signal intensity involving the right greater wing of the sphenoid bone.
B, ADC map shows low signal intensity at this region with a mean ADC value of 0.84 ± 0.30 x 10–3 mm2/s, suggestive of tumor infiltration, which was proved on bone marrow biopsy.
| |
View larger version (69K):
[in this window]
[in a new window]
|
Fig 6. Posttreatment changes after surgery and radiation therapy.
A, Axial postcontrast T1WI shows an ill-defined, mildly enhancing mass at the region of the ethmoidal sinuses. Recurrence was suspected.
B, ADC map shows high signal intensity at the site of the lesion denoting posttreatment fibrous tissue, which was proved by biopsy. The mean ADC value at the site of the posttreatment changes was 1.89 ± 0.19 x 10–3 mm2/s.
| |
View larger version (84K):
[in this window]
[in a new window]
|
Fig 7. Posttreatment changes after surgery and radiation therapy.
A, Axial postcontrast T1WI shows a small ill-defined enhancing lesion at the site of the right parotid gland after surgical resection and irradiation. Recurrence could not be differentiated from posttreatment changes.
B, ADC map shows low signal intensity at the site of the lesion with a mean ADC value of 1.07 ± 0.18 x 10–3 mm2/s. Biopsy revealed only attenuated fibrous tissue with no tumor cells.
| |
View larger version (10K):
[in this window]
[in a new window]
|
Fig 8. Box and whisker plot compares the mean ADCs of residual or recurrent tumors and posttreatment changes. The horizontal line is the median (50th percentile) of the measured values, the top and bottom of the box represent the 25th and 75th percentiles, respectively, and whiskers indicate the range from the largest to smallest observed data points. Note that despite the overlap between the ADC values of both groups, the ADCs of posttreatment changes are significantly higher than that of residual or recurrent tumors.
| |
